Targeting microRNAs in Pathological Hypertrophy and Cardiac Failure

Author(s): Dongchao Lv, Jingqi Liu, Cuimei Zhao, Qi Sun, Qiulian Zhou, Jiahong Xu, Junjie Xiao

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 15 , Issue 6 , 2015

Become EABM
Become Reviewer
Call for Editor


MicroRNAs (miRNAs) are a novel class of endogenous, short, non-coding, posttranscriptional RNAs, which play important roles in regulating lots of important biological functions. Evidences show that altered expression of miRNAs are involved in pathological hypertrophy and cardiac failure, making it possible to target miRNAs as a novel therapy. In this review, we focus on very recent progresses in the regulation of miRNAs in pathological hypertrophy and cardiac failure. In addition, we also discuss the potential of using miRNAs as a new therapy for pathological hypertrophy and cardiac failure.

Keywords: Cardiac failure, microRNA, pathological hypertrophy, therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 22 April, 2015
Page: [475 - 478]
Pages: 4
DOI: 10.2174/1389557515666150324124751
Price: $65

Article Metrics

PDF: 38